Our study found that the IL-1R blockade alleviated astrocyte IL-1R levels, NF-κB phosphorylation and C3 levels induced by CUMS, demonstrating that astrocyte IL-1R/NF-κB/C3 mediates the pathophysiology of depression. This evidence concerns the gene IL1R1 and depressive symptom measurement.